<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font17">WNL </span>
   <span class="font14">ZIKV </span>
   <span class="font14">with </span>
   <span class="font14">Mild </span>
   <span class="font14">Minimal </span>
   <span class="font14">Moderate </span>
   <span class="font14">were </span>
   <span class="font13">for </span>
   <span class="font13">was </span>
   <span class="font12">mice </span>
   <span class="font12">from </span>
   <span class="font12">vaccine </span>
   <span class="font12">that </span>
   <span class="font12">virus </span>
   <span class="font11">protein </span>
   <span class="font11">using </span>
   <span class="font11">vaccinated </span>
   <span class="font11">EDIII </span>
   <span class="font11">neutralizing </span>
   <span class="font11">(Figure </span>
   <span class="font11">Zika </span>
   <span class="font11">{background </span>
   <span class="font11">against </span>
   <span class="font11">viral </span>
   <span class="font11">DNA </span>
   <span class="font11">challenge </span>
   <span class="font11">antibodies </span>
   <span class="font11">The </span>
   <span class="font11">[]. </span>
   <span class="font11">anti-EDIII </span>
   <span class="font11">envelope </span>
   <span class="font11">margin </span>
   <span class="font11">antigen </span>
   <span class="font11">{border-style </span>
   <span class="font11">all </span>
   <span class="font11">control </span>
   <span class="font11">which </span>
   <span class="font10">protection </span>
   <span class="font10">px;} </span>
   <span class="font10">response </span>
   <span class="font10">vaccines </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">EDIII-CH </span>
   <span class="font10">antibody </span>
   <span class="font10">not </span>
   <span class="font10">titers </span>
   <span class="font10">are </span>
   <span class="font10">different </span>
   <span class="font10">domain </span>
   <span class="font10">ChAdOx-EDIII </span>
   <span class="font10">but </span>
   <span class="font10">this </span>
   <span class="font10">RNA </span>
   <span class="font10">after </span>
   <span class="font10">high </span>
   <span class="font10">performed </span>
   <span class="font10">sera </span>
   <span class="font10">showed </span>
   <span class="font10">three </span>
   <span class="font10">used </span>
   <span class="font10">day </span>
   <span class="font10">immune </span>
   <span class="font10">immunized </span>
   <span class="font10">induced </span>
   <span class="font10">neutralization </span>
   <span class="font10">... </span>
   <span class="font10">ELISA </span>
   <span class="font10">each </span>
   <span class="font10">group </span>
   <span class="font10">responses </span>
   <span class="font10">shown </span>
   <span class="font10">Î¼L </span>
   <span class="font10">ChAdOx </span>
   <span class="font10">III </span>
   <span class="font10">between </span>
   <span class="font10">dengue </span>
   <span class="font10">groups </span>
   <span class="font10">into </span>
   <span class="font10">our </span>
   <span class="font10">results </span>
   <span class="font10">Â°C </span>
   <span class="font10">BALB/c </span>
   <span class="font10">DENV </span>
   <span class="font10">Nile </span>
   <span class="font10">anti-ZIKV </span>
   <span class="font10">days </span>
   <span class="font10">mouse </span>
   <span class="font10">protective </span>
   <span class="font10">protein-based </span>
   <span class="font10">G.D.L., </span>
   <span class="font10">Virus </span>
   <span class="font10">West </span>
   <span class="font10">animal </span>
   <span class="font10">both </span>
   <span class="font10">cells </span>
   <span class="font10">challenge, </span>
   <span class="font10">detected </span>
   <span class="font10">efficacy </span>
   <span class="font10">human </span>
   <span class="font10">similar </span>
   <span class="font10">tested </span>
   <span class="font10">upon </span>
   <span class="font10">A.R.-S.; </span>
   <span class="font10">African </span>
   <span class="font10">Antibody </span>
   <span class="font10">UK). </span>
   <span class="font10">also </span>
   <span class="font10">animals </span>
   <span class="font10">clinical </span>
   <span class="font10">could </span>
   <span class="font10">design </span>
   <span class="font10">epitopes </span>
   <span class="font10">following </span>
   <span class="font10">highly </span>
   <span class="font10">immunization </span>
   <span class="font10">mice, </span>
   <span class="font10">none </span>
   <span class="font10">obtained </span>
   <span class="font10">px; </span>
   <span class="font10">through </span>
   <span class="font10">weight </span>
   <span class="font10">{font-family </span>
   <span class="font10">Asian </span>
   <span class="font10">DIII </span>
   <span class="font10">Figure </span>
   <span class="font10">Our </span>
   <span class="font10">RT-PCR </span>
   <span class="font10">S.D., </span>
   <span class="font10">Vaccine </span>
   <span class="font10">ZIKV, </span>
   <span class="font10">[], </span>
   <span class="font10">able </span>
   <span class="font10">before </span>
   <span class="font10">challenged </span>
   <span class="font10">data </span>
   <span class="font10">described </span>
   <span class="font10">due </span>
   <span class="font10">font-size </span>
   <span class="font10">infection </span>
   <span class="font10">load </span>
   <span class="font10">strain </span>
   <span class="font10">under </span>
   <span class="font10">(d) </span>
   <span class="font10">A.H.P., </span>
   <span class="font10">All </span>
   <span class="font10">C.L.-C., </span>
   <span class="font10">IgG </span>
   <span class="font10">[,]. </span>
   <span class="font10">activities </span>
   <span class="font10">analysis </span>
   <span class="font10">approved </span>
   <span class="font10">based </span>
   <span class="font10">brain </span>
   <span class="font10">candidates </span>
   <span class="font10">developed </span>
   <span class="font10">double; </span>
   <span class="font10">four </span>
   <span class="font10">has </span>
   <span class="font10">its </span>
   <span class="font10">low </span>
   <span class="font10">lower </span>
   <span class="font10">mice. </span>
   <span class="font10">mock </span>
   <span class="font10">only </span>
   <span class="font10">other </span>
   <span class="font10">previously </span>
   <span class="font10">show </span>
   <span class="font10">significantly </span>
   <span class="font10">test </span>
   <span class="font10">then </span>
   <span class="font10">two </span>
   <span class="font10">vitro </span>
   <span class="font10">when </span>
   <span class="font10">(a) </span>
   <span class="font10">(c) </span>
   <span class="font10">Animal </span>
   <span class="font10">Dengue </span>
   <span class="font10">EDIII-based </span>
   <span class="font10">For </span>
   <span class="font10">J.L.S.-C., </span>
   <span class="font10">Manchester, </span>
   <span class="font10">O.R.B., </span>
   <span class="font10">PFU </span>
   <span class="font10">UK) </span>
   <span class="font10">Upon </span>
   <span class="font10">adenoviral </span>
   <span class="font10">analyzed </span>
   <span class="font10">assessed </span>
   <span class="font10">blue </span>
   <span class="font10">body </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">candidate </span>
   <span class="font10">collected </span>
   <span class="font10">complete </span>
   <span class="font10">decrease </span>
   <span class="font10">did </span>
   <span class="font10">dimerizing </span>
   <span class="font10">displayed </span>
   <span class="font10">domains </span>
   <span class="font10">elicit </span>
   <span class="font10">elicited </span>
   <span class="font10">flavivirus </span>
   <span class="font10">flaviviruses, </span>
   <span class="font10">have </span>
   <span class="font10">indicated </span>
   <span class="font10">lines </span>
   <span class="font10">loads </span>
   <span class="font10">measured </span>
   <span class="font10">might </span>
   <span class="font10">model </span>
   <span class="font10">monoclonal </span>
   <span class="font10">monomeric </span>
   <span class="font10">more </span>
   <span class="font10">one </span>
   <span class="font10">ovaries </span>
   <span class="font10">platform </span>
   <span class="font10">polyclonal </span>
   <span class="font10">present </span>
   <span class="font10">secretion </span>
   <span class="font10">sequence </span>
   <span class="font10">solid; </span>
   <span class="font10">structural </span>
   <span class="font10">studies </span>
   <span class="font10">target </span>
   <span class="font10">temperature </span>
   <span class="font10">than </span>
   <span class="font10">those </span>
   <span class="font10">titer </span>
   <span class="font10">transfected </span>
   <span class="font10">vivo </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Qiagen, </span>
   <span class="font10">(b) </span>
   <span class="font10">(b). </span>
   <span class="font10">Animals </span>
   <span class="font10">CLC, </span>
   <span class="font10">Domain </span>
   <span class="font10">Each </span>
   <span class="font10">Health </span>
   <span class="font10">Host </span>
   <span class="font10">Immunization </span>
   <span class="font10">J.C., </span>
   <span class="font10">Microbe./j.chom... </span>
   <span class="font10">Not </span>
   <span class="font10">Protein </span>
   <span class="font10">Protein-Based </span>
   <span class="font10">Responses </span>
   <span class="font10">Severe </span>
   <span class="font10">Similar </span>
   <span class="font10">This </span>
   <span class="font10">Viral </span>
   <span class="font10">ZIKV. </span>
   <span class="font10">adenovirus </span>
   <span class="font10">authors </span>
   <span class="font10">bind </span>
   <span class="font10">bold </span>
   <span class="font10">c). </span>
   <span class="font10">capacity </span>
   <span class="font10">challenge. </span>
   <span class="font10">compared </span>
   <span class="font10">conditions </span>
   <span class="font10">confer </span>
   <span class="font10">courier; </span>
   <span class="font10">curve </span>
   <span class="font10">curves </span>
   <span class="font10">delivery </span>
   <span class="font10">demonstrated </span>
   <span class="font10">designed </span>
   <span class="font10">disease </span>
   <span class="font10">doses </span>
   <span class="font10">em; </span>
   <span class="font10">encoding </span>
   <span class="font10">followed </span>
   <span class="font10">fusion </span>
   <span class="font10">gene </span>
   <span class="font10">genetic </span>
   <span class="font10">group. </span>
   <span class="font10">groups. </span>
   <span class="font10">higher </span>
   <span class="font10">humane </span>
   <span class="font10">immunity </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">indicate </span>
   <span class="font10">induction </span>
   <span class="font10">infection. </span>
   <span class="font10">kit </span>
   <span class="font10">levels </span>
   <span class="font10">like </span>
   <span class="font10">limit </span>
   <span class="font10">limited </span>
   <span class="font10">lineage </span>
   <span class="font10">mAbs </span>
   <span class="font10">mammalian </span>
   <span class="font10">mean </span>
   <span class="font10">most </span>
   <span class="font10">neutralize </span>
   <span class="font10">out </span>
   <span class="font10">plasmid </span>
   <span class="font10">potent </span>
   <span class="font10">potential </span>
   <span class="font10">presence </span>
   <span class="font10">previous </span>
   <span class="font10">processed </span>
   <span class="font10">production </span>
   <span class="font10">pt;} </span>
   <span class="font10">purified </span>
   <span class="font10">reached </span>
   <span class="font10">recombinant </span>
   <span class="font10">red </span>
   <span class="font10">related </span>
   <span class="font10">relevant </span>
   <span class="font10">samples </span>
   <span class="font10">structure </span>
   <span class="font10">study, </span>
   <span class="font10">such </span>
   <span class="font10">tetravalent </span>
   <span class="font10">that, </span>
   <span class="font10">these </span>
   <span class="font10">vaccination </span>
   <span class="font10">vaccines, </span>
   <span class="font10">vaccines. </span>
   <span class="font10">weeks </span>
   <span class="font10">within </span>
   <span class="font10">working </span>
   <span class="font10">ÂµL </span>
   <span class="font10">â€" </span>
  </p>
 </body>
</html>
